Investors Watch List: Windstream Holdings (NASDAQ:WIN), Corning Inc. (NYSE:GLW), Dime Community Bancshares Inc. (NASDAQ:DCOM), Arena Pharmaceuticals (NASDAQ:ARNA), Great Southern Bancorp (NASDAQ:GSBC)

On Wednesday shares of Windstream Holdings, Inc. (NASDAQ:WIN) closed at $10.99. Company’s sales growth for last 5 years was 14.20%. Windstream Holdings, Inc. (NASDAQ:WIN) has filled a SC 13G form regarding Communications Sales & Leasing, Inc . Per Windstream Holdings, Inc’s filing, the filler now owns 19.6% of the company, holding 29,385,064 shares.

Corning Inc. (NYSE:GLW) in last trading activity moved down -3.22% to close at $21.36. Company weekly performance is -4.81% while its quarterly performance stands at -11.38%. Corning Inc. (NYSE:GLW) is -14.69% away from its 52 week high. On 21 April, Corning Incorporated (NYSE:GLW) has announced a collaborative agreement with OLEDWorks to develop unique, flexible, and conformable OLED lighting solutions using Corning Willow Glass as an integrated substrate.

On last trading day Dime Community Bancshares Inc. (NASDAQ:DCOM) moved down -0.67% to close at $16.28. Its volatility for the week is 1.96% while volatility for the month is 1.59%. DCOM’s sales growth for past 5 years was -3.70% and its EPS growth for past 5 years was 9.30%. Dime Community Bancshares Inc. (NASDAQ:DCOM) monthly performance is 1.31%. Dime Community Bancshares, Inc. (NASDAQ:DCOM) on 23 April, reported financial results for the quarter ended March 31, 2015. Consolidated net income for the quarter ended March 31, 2015 was $11.8 million, or $0.33 per diluted share, compared to $12.0 million, or $0.33 per diluted share, for the quarter ended December 31, 2014, and $10.0 million, or $0.28 per diluted share, for the quarter ended March 31, 2014.

On Wednesday shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) closed at $4.32. Company’s sales growth for last 5 years was 28.90%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced favorable results from a Phase 1 single-ascending dose clinical trial of APD371, a highly selective and potent agonist of the cannabinoid 2 (CB2) receptor currently in development for the treatment of pain and potentially fibrotic diseases.

On last trading day Great Southern Bancorp Inc. (NASDAQ:GSBC) moved down -1.41% to close at $40.65. Its volatility for the week is 2.61% while volatility for the month is 2.50%. GSBC’s sales growth for past 5 years was 3.30% and its EPS growth for past 5 years was -6.90%. Great Southern Bancorp Inc. (NASDAQ:GSBC) monthly performance is 4.07%. Great Southern Bancorp, Inc. (NASDAQ: GSBC) on 21 April, reported that preliminary earnings for the three months ended March 31, 2015, were$0.83 per diluted common share ($11.5 million available to common shareholders) compared to$0.63 per diluted common share ($8.7 million available to common shareholders) for the three months ended March 31, 2014. For the quarter ended March 31, 2015, annualized return on average common equity was 12.63%, annualized return on average assets was 1.14%, and net interest margin was 4.82%, compared to 10.66%, 0.96% and 4.66%, respectively, for the quarter ended March 31, 2014.

Leave a Reply

Your email address will not be published. Required fields are marked *

*